Compare Applovin Corporation (APP) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applovin Corporation vs Tenet Healthcare Corporation — how do they compare? Applovin Corporation trades at $444 (market cap $170.31B), while Tenet Healthcare Corporation trades at $195 (market cap $17.59B). The key difference: Applovin Corporation is far larger — about 9.7× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.
| APP | THC | |
|---|---|---|
Market Cap | $170.31B | $17.59B |
Sector | Technology | Health |
52-Week High | $733.60 | $244.80 |
52-Week Low | $335.10 | $148.38 |
Enterprise Value | $171.07B | $27.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AppLovin (APP) trades at $506.98, down 2.58% amid recent market volatility, with technical indicators showing a neutral bias. The company demonstrates exceptional profitability with 64.29% net income margins and has beaten earnings estimates for three consecutive quarters. Strong revenue growth is projected to reach $6.2 billion in 2026, though valuation multiples remain elevated with a P/E of 44.09.
The outlook remains positive given analyst consensus of 88% buy ratings and a $644.09 price target, representing 27% upside potential. Key risks include premium valuation sensitivity and competitive pressures in mobile advertising software. Recent news highlights market rotation impacts but also notes AppLovin's gaining e-commerce advertising share according to Jefferies survey (July 10, 2026).
Tenet Healthcare (THC) trades at $204.25, down 1.22% today, with strong fundamental metrics including a P/E of 10.62 and net income margin of 7.79%. Recent quarters show consistent earnings beats, with Q1 2026 EPS of $4.82 exceeding expectations. The stock exhibits a bullish technical trend, supported by moving averages, while oscillators indicate overbought conditions. Positive sentiment is driven by analyst upgrades and growth in outpatient services.
Outlook remains favorable given solid profitability and expansion in ambulatory care, though risks include market volatility and high RSI levels. With 81% analyst buy ratings and a $235.88 consensus target, upside potential exists, but investors should monitor upcoming Q2 2026 earnings on July 24 for confirmation of growth trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applovin Corporation
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
